Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report
<b>Background:</b> This case is unique in demonstrating the reactivation of latent tuberculosis (TB) following co-infection with SARS-CoV-2 and Epstein–Barr virus (EBV) in an otherwise healthy young adult. It highlights a rare clinical scenario in which viral immune dysregulation likely...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pathogens |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-0817/14/5/488 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850126738002018304 |
|---|---|
| author | Iryna Halabitska Pavlo Petakh Valentyn Oksenych Oleksandr Kamyshnyi |
| author_facet | Iryna Halabitska Pavlo Petakh Valentyn Oksenych Oleksandr Kamyshnyi |
| author_sort | Iryna Halabitska |
| collection | DOAJ |
| description | <b>Background:</b> This case is unique in demonstrating the reactivation of latent tuberculosis (TB) following co-infection with SARS-CoV-2 and Epstein–Barr virus (EBV) in an otherwise healthy young adult. It highlights a rare clinical scenario in which viral immune dysregulation likely facilitated TB progression. To date, few reports have explored the complex interplay between COVID-19, EBV reactivation, and TB in a single patient, particularly with isolated extrapulmonary involvement. <b>Case Presentation:</b> A 24-year-old woman presented with persistent low-grade fever, fatigue, night sweats, unintentional weight loss, and progressive cervical and supraclavicular lymphadenopathy. These symptoms emerged shortly after a moderate COVID-19 infection. Laboratory studies revealed elevated inflammatory markers and pronounced lymphopenia. EBV reactivation was confirmed via serology and PCR. Despite antiviral therapy, symptoms persisted, and imaging revealed necrotic lymphadenopathy. Tuberculous lymphadenitis was diagnosed through fine-needle aspiration cytology and PCR detection of <i>Mycobacterium tuberculosis</i>. The patient was treated with a standard anti-tuberculosis regimen, resulting in clinical, radiological, and immunological improvement. <b>Conclusions:</b> This case underscores the importance of considering latent TB reactivation in patients with persistent lymphadenopathy and recent viral infections, particularly in regions with high TB prevalence. It also emphasizes the need for thorough immunological and microbiological assessment in complex post-viral syndromes. The main clinical takeaway is that COVID-19 and EBV co-infection may create a permissive environment for TB reactivation through immune system compromise. |
| format | Article |
| id | doaj-art-fb465dedcb4e4e798521aa8b356bff56 |
| institution | OA Journals |
| issn | 2076-0817 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pathogens |
| spelling | doaj-art-fb465dedcb4e4e798521aa8b356bff562025-08-20T02:33:51ZengMDPI AGPathogens2076-08172025-05-0114548810.3390/pathogens14050488Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case ReportIryna Halabitska0Pavlo Petakh1Valentyn Oksenych2Oleksandr Kamyshnyi3Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Voli Square, 1, 46001 Ternopil, UkraineDepartment of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, UkraineBroegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, NorwayDepartment of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine<b>Background:</b> This case is unique in demonstrating the reactivation of latent tuberculosis (TB) following co-infection with SARS-CoV-2 and Epstein–Barr virus (EBV) in an otherwise healthy young adult. It highlights a rare clinical scenario in which viral immune dysregulation likely facilitated TB progression. To date, few reports have explored the complex interplay between COVID-19, EBV reactivation, and TB in a single patient, particularly with isolated extrapulmonary involvement. <b>Case Presentation:</b> A 24-year-old woman presented with persistent low-grade fever, fatigue, night sweats, unintentional weight loss, and progressive cervical and supraclavicular lymphadenopathy. These symptoms emerged shortly after a moderate COVID-19 infection. Laboratory studies revealed elevated inflammatory markers and pronounced lymphopenia. EBV reactivation was confirmed via serology and PCR. Despite antiviral therapy, symptoms persisted, and imaging revealed necrotic lymphadenopathy. Tuberculous lymphadenitis was diagnosed through fine-needle aspiration cytology and PCR detection of <i>Mycobacterium tuberculosis</i>. The patient was treated with a standard anti-tuberculosis regimen, resulting in clinical, radiological, and immunological improvement. <b>Conclusions:</b> This case underscores the importance of considering latent TB reactivation in patients with persistent lymphadenopathy and recent viral infections, particularly in regions with high TB prevalence. It also emphasizes the need for thorough immunological and microbiological assessment in complex post-viral syndromes. The main clinical takeaway is that COVID-19 and EBV co-infection may create a permissive environment for TB reactivation through immune system compromise.https://www.mdpi.com/2076-0817/14/5/488COVID-19Epstein–Barr virus<i>Mycobacterium tuberculosis</i>lymphopenialymphadenopathyscrofuloderma |
| spellingShingle | Iryna Halabitska Pavlo Petakh Valentyn Oksenych Oleksandr Kamyshnyi Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report Pathogens COVID-19 Epstein–Barr virus <i>Mycobacterium tuberculosis</i> lymphopenia lymphadenopathy scrofuloderma |
| title | Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report |
| title_full | Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report |
| title_fullStr | Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report |
| title_full_unstemmed | Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report |
| title_short | Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report |
| title_sort | reactivation of latent tuberculosis following covid 19 and epstein barr virus coinfection a case report |
| topic | COVID-19 Epstein–Barr virus <i>Mycobacterium tuberculosis</i> lymphopenia lymphadenopathy scrofuloderma |
| url | https://www.mdpi.com/2076-0817/14/5/488 |
| work_keys_str_mv | AT irynahalabitska reactivationoflatenttuberculosisfollowingcovid19andepsteinbarrviruscoinfectionacasereport AT pavlopetakh reactivationoflatenttuberculosisfollowingcovid19andepsteinbarrviruscoinfectionacasereport AT valentynoksenych reactivationoflatenttuberculosisfollowingcovid19andepsteinbarrviruscoinfectionacasereport AT oleksandrkamyshnyi reactivationoflatenttuberculosisfollowingcovid19andepsteinbarrviruscoinfectionacasereport |